VLP BIOTECH, INC.
Biotech · Private
Epitope-focused bivalent anthrax vaccine using virus-like particles (LND-LF-VLP)
- Grants
- $5.8M
- 11 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 12
- 2 granted · 10 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20142015201620172018201920202021
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · A molecularly targeted pre- and post-exposure vaccine for anthrax | $249,612 | |
| Federal grant | Department of Health and Human Services · Phase I · An epitope-focused nanoparticle vaccine for MRSA and biodefense | $273,748 | |
| Federal grant | Department of Health and Human Services · Phase I · An epitope focused nanoparticle vaccine for MRSA and biodefense | $546,129 | |
| Federal grant | Department of Health and Human Services · Phase I · An Epitope-Focused Pediatric RSV Vaccine | $224,141 | |
| Federal grant | Department of Health and Human Services · Phase I · An epitope-focused nanoparticle vaccine for MRSA and biodefense | $272,381 | |
| Federal grant | Department of Health and Human Services · Phase I · A method to determine mRNA isoform frequencies using novel primer generators | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase II · An epitope-focused nanoparticle vaccine for anthrax | $300,000 | |
| Federal grant | Department of Health and Human Services · Phase II · A therapeutic vaccine for chronic hepatitis B | $878,409 | |
| Federal grant | Department of Health and Human Services · Phase II · An epitope-focused nanoparticle vaccine for anthrax | $998,145 | |
| Federal grant | Department of Health and Human Services · Phase II · A therapeutic vaccine for chronic hepatitis B | $858,609 | |
| Federal grant | Department of Health and Human Services · Phase II · An epitope-focused nanoparticle vaccine for anthrax | $983,698 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1503 | HELIX BIOMEDIX INC | — | $17M |
| 1504 | VIVOSCRIPT, INC. | — | — |
| 1505 | WELLSIM BIOMEDICAL TECHNOLOGIES, INC. | — | — |
| 1506 | VLP BIOTECH, INC. | — | — |
| 1507 | KINASENSE, LLC | — | — |
| 1508 | BRITEBIO, INC. | — | — |
| 1509 | MARROWSOURCE THERAPEUTICS INTERNATIONAL | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Immunogens Targeting Anthraxapplication
- Hybrid Virus-like Particles And Use Thereof As A Therapeutic Hepatitis B Vaccineapplication
- Hybrid Hepadnavirus Cores Carrying Multiple Malaria Parasite Epitopesgranted
- Rodent Hepadnavirus Cores With Reduced Carrier-specific Antigenicitygranted
- Hybrid Hepadnavirus Cores Carrying Multiple Malaria Parasite Epitopesapplication
- Hybrid Hepadnavirus Cores Carrying Multiple Epitopes Of Multiple Malaria Parasite Stagesapplication
- Rodent Hepadnavirus Cores With Reduced Carrier-specific Antigenicityapplication
- Rodent hepadnavirus cores with reduced carrier-specific antigenicityapplication
- Palivizumab Epitope-based Virus-like Particlesapplication
- Immunogens Targeting Anthraxapplication
- Hybrid Virus-like Particles And Uses Thereof As A Therapeutic Hepatitis B Vaccineapplication
- Hybrid Virus-like Particles And Uses Thereof As A Therapeutic Hepatitis B Vaccineapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.